Wearables May Boost T2D Mobility
Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.
By
Kathryn Wighton
May 11, 2026
Clinical Scorecard: Wearable, Physiotherapy-Guided Exercise Combination Could Show Benefit in T2D
At a Glance
Category Detail
Condition Type 2 Diabetes (T2D) with Diabetic Kidney Disease Key Mechanisms Physiotherapist-guided exercise combined with wearable device feedback Target Population Outpatients with type 2 diabetes and diabetic kidney disease Care Setting Outpatient physiotherapy and multidisciplinary care
Key Highlights
Intervention group showed a 39-m increase in 6-minute walk distance Glycated hemoglobin decreased by 0.89 percentage points in the intervention group No adverse events related to the intervention were reported Adherence to exercise was feasible with 20 of 25 patients exercising at least three times per week No significant difference in estimated glomerular filtration rate between groups Guideline-Based Recommendations
Diagnosis
Monitor 6-minute walk distance as a measure of exercise capacity Management
Implement physiotherapist-guided exercise with wearable feedback for T2D patients Monitoring & Follow-up
Regularly assess glycated hemoglobin and exercise adherence Risks
Caution in interpreting renal findings due to potential influence of muscle mass on creatinine estimates Patient & Prescribing Data
Outpatients with type 2 diabetes and diabetic kidney disease
Combination of physiotherapy and wearable technology improves exercise capacity and metabolic outcomes
Clinical Best Practices
Encourage gradual increase in physical activity by at least 500 steps above baseline Utilize data from wearable devices to tailor exercise plans during physiotherapy sessions Monitor for potential adverse events and ensure patient safety during exercise References
